4528 Stock Overview
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 6/6 |
Ono Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,809.00 |
| 52 Week High | JP¥2,849.00 |
| 52 Week Low | JP¥1,809.00 |
| Beta | 0.16 |
| 11 Month Change | -9.30% |
| 3 Month Change | -15.94% |
| 1 Year Change | -32.18% |
| 33 Year Change | -26.16% |
| 5 Year Change | -25.69% |
| Change since IPO | 47.07% |
Recent News & Updates
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 03
We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25Recent updates
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 03We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27Shareholder Returns
| 4528 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -9.7% | -2.2% | -1.5% |
| 1Y | -32.2% | 16.0% | 12.1% |
Return vs Industry: 4528 underperformed the JP Pharmaceuticals industry which returned 14.8% over the past year.
Return vs Market: 4528 underperformed the JP Market which returned 12.2% over the past year.
Price Volatility
| 4528 volatility | |
|---|---|
| 4528 Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4528 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4528's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1717 | 3,853 | Gyo Sagara | www.ono-pharma.com |
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv tablets for type 2 diabetes; Forxiga tablets for diabetes; Onoact Intravenous Infusion for tachyarrhythmia; Opalmon tablets to treat peripheral circulatory disorder; Coralan for chronic heart failure; Orencia injections for rheumatoid arthritis; Rivastach patches for Alzheimer’s disease; Ongentys tablets for Parkinson’s disease; Parsabiv, an intravenous infusion for dialysis patients; Staybla tablets for overactive bladder; Onon capsules and Dry Syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as Recalbon tablets for osteoporosis.
Ono Pharmaceutical Co., Ltd. Fundamentals Summary
| 4528 fundamental statistics | |
|---|---|
| Market cap | JP¥849.70b |
| Earnings (TTM) | JP¥95.13b |
| Revenue (TTM) | JP¥484.30b |
8.9x
P/E Ratio1.8x
P/S RatioIs 4528 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4528 income statement (TTM) | |
|---|---|
| Revenue | JP¥484.30b |
| Cost of Revenue | JP¥119.24b |
| Gross Profit | JP¥365.06b |
| Other Expenses | JP¥269.93b |
| Earnings | JP¥95.13b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 202.52 |
| Gross Margin | 75.38% |
| Net Profit Margin | 19.64% |
| Debt/Equity Ratio | 19.0% |
How did 4528 perform over the long term?
See historical performance and comparisonDividends
4.4%
Current Dividend Yield40%
Payout RatioDoes 4528 pay a reliable dividends?
See 4528 dividend history and benchmarks| Ono Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 49 days |
| Days until Dividend pay date | 17 days |
Does 4528 pay a reliable dividends?
See 4528 dividend history and benchmarks